|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/127 | |
| A61K 45/06 | |||
| A61K 48/00 | |||
| A61K 9/51 | |||
| A61K 31/58 |
| (11) | Patento numeris | 3454835 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17721707.2 |
| Europos patento paraiškos padavimo data | 2017-05-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/060891 |
| Data | 2017-05-08 |
| (87) | Numeris | WO 2017/194454 |
| Data | 2017-11-16 |
| (30) | Numeris | Data | Šalis |
| 201662333574 P | 2016-05-09 | US | |
| 201662359429 P | 2016-07-07 | US | |
| 201762449623 P | 2017-01-24 | US |
| (72) |
LINDFORS, Lennart, SE
KJELLMAN, Tomas, SE
|
| (73) |
Astrazeneca AB,
151 85 Södertälje,
SE
|
| (54) | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF |
| LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF |